Login / Signup

Safety of the second dose of the ChAdOx1 nCoV-19 vaccine in people with persistent anti-platelet factor 4 antibodies.

Noppacharn UaprasertSasinipa TrithiphenAutcharaporn SukpermBenjaporn AkkawatPhandee WatanaboonyongcharoenRattaporn VichitratchaneekornThanisa TongbaiWatsamon JantarabenjakulLeilani PaitoonpongPonlapat Rojnuckarin
Published in: Research and practice in thrombosis and haemostasis (2021)
Keyphrases